A conversation with Steve Collis, AmerisourceBergen CEO
Fix the Drug Shortage Problem- Now
2011 Product Security Report: Back to the Future
Industry is gearing up for another go at e-pedigree and anti-counterfeiting safeguards.
Bloodied But Unbowed on the Personalized Medicine Battlefront
Do Dendreon’s troubles with over-optimistic sales forecasts put a cap on the promise of personalized medicine?
Global Logistics Providers Offer Real-time Monitoring of Drug Shipments, Worldwide
Satellite and cellular technologies, combined with advanced electronic sensors are creating new options for pharma shippers
The Alternative Universes of Big PBMs and Little Independent Pharmacies
Back to the Future With Track-and-Trace
Cold Chain Regulation Tightens Globally
The recent PDA Cold Chain conference highlighted increased regulatory scrutiny of shipping processes, even while logistics capacity and technology expand
Healthcare Exchange Bids for Prototyping a Track-and-Trace System
GHX, a major player in med-surg supply management for healthcare providers, looks to extend its e-commerce platform to handling pharma e-pedigrees
Industry Grapples With the Growing Complexity of Contract Manufacturing Supply Chains
While all the market indicators point to healthy growth, managing the CMO relationship is a challenge. Industry collaboration might fill in the regulatory gap
Adverse Event Reporting: At the Front Lines of Drug Safety
Industry and regulators are taking steps to revolutionize the basic regulatory function of collecting and analyzing adverse medical events
HDMA 2010-2011 Factbook Updates Distributor IT Efforts
EDI use is slowly increasing, while GS1 standards compliance is skimpy
UPS and Endo Pharmaceuticals Go Live With Controlled-Substances Ordering
The implementation, executed with IT vendor Axway, has shaved nearly 18 days off order cycle times
What's the Buzz About Multichannel Marketing?
MCM is but one way to get a focus on the explosive growth of new communication channels to physicians and patients
2010 Product Security Report
More pieces for industry-wide track-and-trace are falling into place, but there’s no rush to authenticate products
Getting Physician Databases Right
The seemingly routine process of identifying and locating prescribing physicians is becoming a critical industry function
Booming Biopharma Cold-Chain Market Attracts High Industry Turnout
Record numbers of attendees and exhibitors came together at Philadelphia meeting
Are Pharma Brands Worth Protecting?
The Path Ahead for Enterprise Computing
As IT vendors leap into cloud computing, clients in life sciences struggle to keep the data flowing through the organizations
Software as a Service (SaaS) Will Show Robust Growth But Is Not a 'Panacea,' Says Gartner
Research group finds ‘bad practices’ in current implementations as market grows to $8.5 billion
Mid-Course Corrections for REMS
Today's Sales Reps: Medical Professionals, Order Takers, Delivery Staff--or Something Else?
Court rulings begin to swing toward categorizing pharma reps as hourly workers
Global Pharma Logistics Offers More Options
Dramatic traffic downturn makes providers more eager to offer service options; meanwhile, TSA 100% inspection rule looms for air carriers
Serialization Efforts Energize Track-and-Trace Technology
By fits and starts, pharma and healthcare providers are moving ahead on IT technologies to layer track-and-trace capabilities on supply chains
With Healthcare Reform, Aggregate Spending Jumps as a Regulatory Priority
The growing number of states with laws now are joined by the “51st state”: the federal government
Drug-Delivery Technologies for Controlled Release Score With Manufacturers
The types of delivery mechanisms that vary the uptake of a drug are multiplying
Spotlight on the EMD Serono Specialty Digest, 6th Edition
The biopharma company’s annual report provides clarity to a confusing marketplace
'Revenue Management' Comes to the Rescue of Pharma's Complex Pricing Environment
‘Revenue Management’ Comes to the Rescue of Pharma’s Complex Pricing Environment
New Study Sees Double-Digit Growth in Cold-Chain Services for Life Sciences
Faster-than-average growth of biologics, more global trade to emerging countries, and widening regulatory requirements will propel the activity
How Well Can Biopharma Protect Itself Against Theft?